Potential probiotic (<i>L. plantarum, L. pentosus, P. pentosaceus, W. cibaria</i> and <i>L. rhamnosus</i>) alleviates memory impairment in lipopolysaccharide‐induced cognitive dysfunction and neurotoxicity in mice brain via protection against neuroin

Abstract Background The impact of probiotics as gut and immunological modulator in restoring gut microbial balance and immune cells expression have generated much attention in the health sector. Its inhibitory effect on bacterial translocation and associated neural inflammatory processes has been reported. However, there is scarcity of data on its neuroprotective impact against neuroinflammation‐associated neurodegeneration and memory impairment. Therefore, we tested the neuroprotective capabilities of the probiotic strains against lipopolysaccharide (LPS)‐induced neurotoxicity and memory impairment in mice. Method Forty eight mice (n = 12) weighing 25 ‐ 30 g were randomly classified into four groups consisting of probiotic strains (10 7 CFU/ml, orally), donepezil (3 mg/kg, intraperitoneally (i.p.)), normal saline (10 ml/kg, orally), and LPS (0.25 mg/kg i.p) group. LPS was injected 60 min after treatments for seven days. Novel object recognition (NORT) and Y‐maze tests were performed 24 h following the last treatment to assess cognitive functions. Dendritic spine of the dentate gyrus was stained with Golgi cox. Immunohistochemistry detected brain‐derived neurotrophic factor (BDNF) expression as well as Iba 1 and amyloid beta activation in the hippocampus and prefrontal cortex, while enzyme‐linked immunosorbent assay was used to measure neuroinflammation (tumor necrosis factor‐α (TNF‐α), interleukin‐1 beta (IL‐1β), interleukin‐12 (IL‐12), and interferon gamma (IFN‐γ)) and oxidative stress biomarkers (glutathione (GSH) and malondialdehyde (MDA)). Result Probiotics reduced elevation of pro‐inflammatory cytokines, MDA levels and enhanced GSH levels in the brain. Probiotic strains enhanced BDNF expressions, reduced microglia and amyloid beta activation in the hippocampus and prefrontal cortex of LPS‐induced mice. Conclusion These finding show that probiotic strains may possess neuroprotective effect against LPS‐induced cognitive impairment and neurodegeneration via antioxidant and anti‐inflammatory mechanisms.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2024-12-01
DOI
https://doi.org/10.1002/alz.089920
Primary Topic
Gut microbiota and health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potential probiotic (L. plantarum, L. pentosus, P. pentosaceus, W. cibaria and L. rhamnosus) alleviates memory impairment in lipopolysaccharide‐induced cognitive dysfunction and neurotoxicity in mice brain via protection against neuroin

Funmilayo Adeniyi, Juliet Nnenda Olayinka, Abiola Oluwatosin Obisesan, Adedamola Adediran Fafure et al.
Alzheimer s & Dementia
Gut microbiota and health
article

Potential probiotic (L. plantarum, L. pentosus, P. pentosaceus, W. cibaria and L. rhamnosus) alleviates memory impairment in lipopolysaccharide‐induced cognitive dysfunction and neurotoxicity in mice brain via protection against neuroin

Funmilayo Adeniyi, Juliet Nnenda Olayinka, Abiola Oluwatosin Obisesan, Adedamola Adediran Fafure, Olusegun Adebayo Adeoluwa, Samuel O Dodo
article en

Abstract

Abstract Background The impact of probiotics as gut and immunological modulator in restoring gut microbial balance and immune cells expression have generated much attention in the health sector. Its inhibitory effect on bacterial translocation and associated neural inflammatory processes has been reported. However, there is scarcity of data on its neuroprotective impact against neuroinflammation‐associated neurodegeneration and memory impairment. Therefore, we tested the neuroprotective capabilities of the probiotic strains against lipopolysaccharide (LPS)‐induced neurotoxicity and memory impairment in mice. Method Forty eight mice (n = 12) weighing 25 ‐ 30 g were randomly classified into four groups consisting of probiotic strains (10 7 CFU/ml, orally), donepezil (3 mg/kg, intraperitoneally (i.p.)), normal saline (10 ml/kg, orally), and LPS (0.25 mg/kg i.p) group. LPS was injected 60 min after treatments for seven days. Novel object recognition (NORT) and Y‐maze tests were performed 24 h following the last treatment to assess cognitive functions. Dendritic spine of the dentate gyrus was stained with Golgi cox. Immunohistochemistry detected brain‐derived neurotrophic factor (BDNF) expression as well as Iba 1 and amyloid beta activation in the hippocampus and prefrontal cortex, while enzyme‐linked immunosorbent assay was used to measure neuroinflammation (tumor necrosis factor‐α (TNF‐α), interleukin‐1 beta (IL‐1β), interleukin‐12 (IL‐12), and interferon gamma (IFN‐γ)) and oxidative stress biomarkers (glutathione (GSH) and malondialdehyde (MDA)). Result Probiotics reduced elevation of pro‐inflammatory cytokines, MDA levels and enhanced GSH levels in the brain. Probiotic strains enhanced BDNF expressions, reduced microglia and amyloid beta activation in the hippocampus and prefrontal cortex of LPS‐induced mice. Conclusion These finding show that probiotic strains may possess neuroprotective effect against LPS‐induced cognitive impairment and neurodegeneration via antioxidant and anti‐inflammatory mechanisms.

Alzheimer s & DementiaVol. 20(S6)
Afe Babalola University (NG)
Openalex Percentile: Top 78%
Gut microbiota and health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.